Back to Market Feed

XIFAXAN 550 MG TABLET

$55.2802per EA

Strength

550 mg/1

Manufacturer

Salix Pharmaceuticals Inc.

NDC

65649030302

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

9/17/2025

Active Ingredients

Approval Type

New Drug (NDA)

FDA Application

On Market Since

5/1/2010

Pharmacological Classes

Rifamycin Antibacterial

Rifamycins

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.1%

3Y

+9.2%

5Y

+25.5%

All

+158.7%

Generic Alternatives

1 alternative • Same active ingredient

XIFAXAN 550 MG TABLET

65649030303•Salix Pharmaceuticals Inc.

Related Drugs

Same classification

PRIFTIN 150 MG TABLET

00088210224•Sanofi-Aventis U.S. LLC

TALICIA DR 10-250-12.5 MG CAP

57841115002•RedHill Biopharma Ltd